Skip to content

Clinical Trial for the Validation of AR Based Neuronavigation System

Clinical Trial for the Evaluation of the Accuracy of Augmented Reality Based Neuronavigation System

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05776706
Enrollment
80
Registered
2023-03-20
Start date
2025-05-01
Completion date
2027-12-31
Last updated
2024-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Neoplasms, Cerebral Aneurysm, Cerebral Arteriovenous Malformation, Navigation, Spatial

Keywords

augmented reality, neuronavigation, brain neoplasms, cerebral arteriovenous malformation, cerebral aneurysm

Brief summary

The goal of this clinical trial is to test augmented reality (AR) based neuronavigation system in surgeries for patients of brain neoplasm or cerebral vascular disease. The main questions it aims to answer are: • AR based neuronavigation system can achieve accuracy that is not inferior to conventional intraoperative navigation system. Participants will participate the study after informed consent. When participants undergo surgery for their brain tumor, we will set up 2 types of neuronavigation, conventional navigation system and developed AR based neuronavigation system. Surgeon will plan and conduct surgery based on only conventional navigation system, but 3D errors at several selected points between two types of navigation will be measured and analyzed.

Detailed description

Being developed AR navigation were reported in our following papers: 1. Dho YS, et al., Development of an inside-out augmented reality technique for neurosurgical navigation. Neurosurgical Focus. 2021 Aug 1;51(2):E21. (doi.org/10.3171/2021.5.FOCUS21184) 2. Moon HC, et al., Navigation of frameless fixation for gamma knife radiosurgery using fixed augmented reality. Scientific Reports. 2022 Mar 16;12(1):1-0. (doi.org/10.3171/2021.5.FOCUS21184) This study aims to evaluate the accuracy of anatomical localization of a newly developed augmented reality-based neurosurgery navigation. After 3-dimensional (3D) modeling of the brain of a patient with brain tumor or cerebral vascular disease through 3D image segmentation extraction and modeling, the Augmented Reality (AR)-based navigation developed by this research team can be used with a commercially available visualization device, such as iPad, iPhone, and Hololens2, to evaluate the accuracy. The AR-based navigation obtained approval from the Ministry of Food and Drug Safety of Republic of Korea (class 2 medical device) in February 2022. Through this clinical tria that compare accuracy with existing conventional intraoperative neuronavigation system, we will evaluate whether it shows equivalent performance to replace the existing navigation.

Interventions

DIAGNOSTIC_TESTAR-based navigation

The surgeon will perform all surgical planning and operations with reference to the existing navigation. In this process, the errors of the existing navigation and the newly developed navigation are measured and compared in 3D at several points, and the points are as follows. 1. Fiducial markers 2. Nasion 3. Tumor's margin (anterior, posterior, superior, inferior)

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

Patients who undergo craniotomy using navigation system for cerebral disease in a single institution

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Adult patients aged 18 years or older who underwent MRI or CT scan due to brain tumor or cerebrovascular disease * Adult patients aged 18 years or older who need surgical treatment using navigation for brain tumor or cerebrovascular disease

Exclusion criteria

* Cases where application of navigation is not necessary according to the judgment of the researcher or surgeon * When the patient or guardian does not agree * Patients with anatomical deformation due to previous surgery or requiring emergency surgery

Design outcomes

Primary

MeasureTime frameDescription
The degree of 3-dimensional error at each measurement points (mm)6 hoursFiducial markers, nasion
The degree of 3-dimensional error at each measurement points (mm) after durotomy6 hoursTumor's margin, ICA bifurcation, et al.

Secondary

MeasureTime frameDescription
Non-inferiority of AR-based navigation compared to conventional navigation12 monthsStatistical comparison of the average value between the error with the actual position of conventional navigation and the error with the actual position of AR navigation.
Time required to set up and use each navigation6 hoursTime required to match conventional navigation and AR navigation, respectively.
Economic analysis for each navigation12 monthsEconomic benefits that can be expected if AR-based navigation can replace conventional navigation will be assessed. Cost for surgery, cost of whole admission period, and hospital day will be evaluated.

Countries

South Korea

Contacts

Primary ContactHo Kang, MD
kang.ho85@gmail.com+821085571217
Backup ContactChul-Kee Park, MD, PhD
nsckpark@snu.ac.kr+82220720347

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026